The Research On The Relationship Between Corporate Governance And Operating Performance Of China’s Biological Medicine Listed Company

The bio-pharmaceutical industry as an emerging industry, pharmaceutical industry, the most active and fastest-growing areas, is recognized as the21st century’s most promising industries.Has historically focused on the development of bio-pharmaceutical industry worldwide, China’s bio-pharmaceutical companies in the process of development, in the relevant policies to encourage continuous introduction of macroeconomic trends good environment from the perspective of corporate governance, upgrading governance standards toeffective means of promoting reform, and comprehensively improve its operating performance with international standards, this is a bio-pharmaceutical industry is worthy of deep-seated to explore and urgent subject.From the direction of corporate governance, governance structure and operating performance of listed companies on the bio-pharmaceutical industry in order to determine effective reasonable degree of bio-pharmaceutical industry governance structure, which put forward the relevant recommendations to further improve and enhance the governance structure and performance of the industry.Analysis of external governance point of view to observe the impact of corporate governance by the products, funds, managers, financial and factor markets, as well as government departments.Analysis point of view of internal governance, corporate governance structure is to maintain a high degree of consistency related to the specific organization and business activities with the company’s target planning to improve its operating results, and the composition of the shareholders’ meeting with the Board, managersBoard of Supervisors.In view of the relationship between corporate governance and business performance and the company’s internal governance and external market is imperfect and immature, the external governance of the data difficult to collect.In this paper, is the angle of internal governance, corporate governance structure of bio-pharmaceutical industry and business performance.As of the end of2010, Shanghai, Shenzhen Stock Exchange bio-pharmaceutical industry,more than60listed companies in the sample, the Chinese biomedical listed companies and good corporate governance structure of performance indicators in the definition and presentation of relevant variables and hypotheses on the basis of comprehensiveuse of relevant statistical software (Excel, SPSS, EVIEWS), expand the correlation and multiple regression analysis, empirical research corporate governance structure and operating performance of the industry, and ultimately the industry structure of listed companies to evaluate the effectiveness of the performance, whichgiven the theoretical auxiliary reference proposal for the realization of its good performance.